Polyphosphazenes for the delivery of biopharmaceuticals

dc.contributor.affiliationUniversidade de Santiago de Compostela. Centro de Investigación en Medicina Molecular e Enfermidades Crónicasgl
dc.contributor.authorHsu, Wei-Hsin
dc.contributor.authorCsaba, Noemi Stefania
dc.contributor.authorAlexander, Cameron
dc.contributor.authorGarcía Fuentes, Marcos
dc.date.accessioned2020-09-01T06:41:48Z
dc.date.available2020-11-14T02:00:07Z
dc.date.issued2020
dc.descriptionThis is the peer reviewed version of the following article: Hsu, W‐H., Csaba, N., Alexander, C., Garcia‐Fuentes, M. (2020), Polyphosphazenes for the delivery of biopharmaceuticals. J Appl Polym Sci, 137, 48688. doi: https://doi.org/10.1002/app.48688, which has been published in final form at https://doi.org/10.1002/app.48688. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versionsgl
dc.description.abstractPolyphosphazenes (PPZs) are a relatively new family of polymers based on a nitrogen- phosphorous backbone where organic side-groups can be grafted. The synthetic route to PPZs is highly versatile such that it is possible to add many different functionalities that change completely the physicochemical and biological properties of the polymers. For instance, PPZs can be designed with a variety of organic side groups that render these materials biodegradable and highly biocompatible. Based on these positive features, PPZs have been explored for many biomedical applications including the design of numerous advanced drug delivery systems. In this area, PPZs have been particularly investigated as materials for the formulation of biopharmaceuticals of high added value. These include protein- and polynucleotide-based medicines, applications where PPZ carriers have obtained very positive results in pre-clinical models. A further area of major interest for PPZs has been vaccination, where these materials have obtained excellent results in vivo as polymer adjuvants and have advanced to clinical evaluation.gl
dc.description.peerreviewedSIgl
dc.description.sponsorshipThis work has been funded by Ministerio de Economía y Competitividad (MINECO-RETOS, Grant MAT2017-84361-R, Feder Funds) and Xunta de Galicia (Grupos de Referencia Competitiva, Feder Funds) to MGF and Engineering and Physical Sciences Research Council Grants EP/N006615/1, EP/ N03371X/1 to CA. WHH was a recipient of a contract from EU Erasmus Mundus NanoFar joint doctorate programgl
dc.identifier.citationHsu, W‐H., Csaba, N., Alexander, C., Garcia‐Fuentes, M. (2020), Polyphosphazenes for the delivery of biopharmaceuticals. J Appl Polym Sci, 137, 48688. doi: https://doi.org/10.1002/app.48688gl
dc.identifier.doi10.1002/app.48688
dc.identifier.essn1097-4628
dc.identifier.issn0021-8995
dc.identifier.urihttp://hdl.handle.net/10347/23247
dc.language.isoenggl
dc.publisherWileygl
dc.relation.publisherversionhttps://doi.org/10.1002/app.48688gl
dc.rights© 2019 Wiley Periodicals, Inc. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versionsgl
dc.rights.accessRightsopen accessgl
dc.subjectPolyphosphazenesgl
dc.subjectSynthesisgl
dc.subjectGene deliverygl
dc.subjectVaccine deliverygl
dc.subjectProtein deliverygl
dc.titlePolyphosphazenes for the delivery of biopharmaceuticalsgl
dc.typejournal articlegl
dc.type.hasVersionAMgl
dspace.entity.typePublication
relation.isAuthorOfPublication49cbfa5c-f232-4cdf-881a-acedae6c99bc
relation.isAuthorOfPublication186becc2-6335-4e40-9df7-17f63a37d9d2
relation.isAuthorOfPublication.latestForDiscovery49cbfa5c-f232-4cdf-881a-acedae6c99bc

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
JAPS 2019 Minerva.pdf
Size:
994.23 KB
Format:
Adobe Portable Document Format
Description:
Publication (post-print)